Oxford Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,835
Closed -$1.61M 556
2025
Q4
$1.61M Buy
+15,835
New +$1.27M 0.59% 28
2025
Q2
Sell
-7,604
Closed -$329K 605
2025
Q1
$329K Buy
+7,604
New +$385K 0.15% 235
2019
Q2
Sell
-3,845
Closed -$333K 1783
2019
Q1
$333K Buy
+3,845
New +$327K 0.01% 1381
2017
Q3
Sell
-165,287
Closed -$5.85M 1578
2017
Q2
$5.85M Buy
+165,287
New +$5.1M 0.12% 182
2015
Q3
Sell
-298,941
Closed -$8.89M 652
2015
Q2
$8.89M Buy
298,941
+205,699
+221% +$5.17M 0.24% 92
2015
Q1
$2.05M Sell
93,242
-178,880
-66% -$4.54M 0.05% 357
2014
Q4
$7.75M Sell
272,122
-196,803
-42% -$4.79M 0.17% 116
2014
Q3
$9.14M Sell
468,925
-146,890
-24% -$2.69M 0.21% 96
2014
Q2
$10.5M Buy
+615,815
New +$8.48M 0.34% 60
2013
Q4
Sell
-198,377
Closed -$2.34M 725
2013
Q3
$2.34M Sell
198,377
-101,104
-34% -$1.3M 0.05% 417
2013
Q2
$4.17M Buy
+299,481
New +$3.25M 0.11% 295

Other funds holding EXAS

Oxford Asset Management's EXAS Position: Q1 2026 in Review

Oxford Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 15,835 shares — an estimated $1.61M sold.

Oxford Asset Management first reported a position in EXAS in Q2 2013 and held it in 11 quarters. The position peaked at $10.5M in Q2 2014. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Oxford Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Oxford Asset Management sold 15,835 Exact Sciences shares in Q1 2026, an estimated $1.61M.
  • Oxford Asset Management first reported a position in Exact Sciences in Q2 2013 and held it in 11 quarters.
  • Oxford Asset Management's Exact Sciences position peaked at $10.5M in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.